✦ LIBER ✦

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

✍ Scribed by Homnick, Carl F.; Kuo, Michelle S.; Bell, Ian M.; Erb, Jill M.; Freidinger, Roger M.; Gallicchio, Steven N.; Guare, James P.; Guidotti, Maribeth T.; Halpin, Rita A.; Hobbs, Doug W.

Book ID: 111921733
Publisher: American Chemical Society
Year: 1998
Tongue: English
Weight: 300 KB
Volume: 41
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm9800797

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Development of Oral

ChemInform Abstract: Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy] -2-methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines.

✍ I. M. BELL; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 41 KB 👁 2 views

1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2-

1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.

✍ Williams, Peter D.; Clineschmidt, Bradley V.; Erb, Jill M.; Freidinger, Roger M. 📂 Article 📅 1995 🏛 American Chemical Society 🌐 English ⚖ 380 KB

ChemInform Abstract: 1-(1-(4-((N-Acetyl-

ChemInform Abstract: 1-(1-(4-((N-Acetyl-4-piperidinyl)oxy)-2-methoxybenzoyl)piperidin-4-yl)- 4H-3,1-benzoxazin-2(1H)-one (L-371,257): A New, Orally Bioavailable, Non-Peptide Oxytocin Antagonist.

✍ P. D. WILLIAMS; B. V. CLINESCHMIDT; J. M. ERB; R. M. FREIDINGER; M. T. GUIDOTTI; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

Synthesis of 3-{4-[4-dimethylamino-6-(4-

Synthesis of 3-{4-[4-dimethylamino-6-(4-methyl-2-oxo-2H-chromen-7-yloxy)-[1,3,5]triazin-2-ylamino]-phenyl}-2-phenyl-5-(4-pyridin-2-yl-piperazin-1-ylmethyl)-thiazolidin-4-one and their biological evaluation

✍ Divyesh Patel, Premlata Kumari, Navin Patel 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 419 KB

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB

Generation of Cyclopenta[c]piperidines a

Generation of Cyclopenta[c]piperidines and Pyrrolo[3,4-c]piperidines—Potential Substance P Antagonists—from Adducts of Cyclic Dienophiles and 5-Chloro-6-methyl-3-phenyl-2H-1,4-oxazin-2-one

✍ Xiujuan Wu; Suzanne Toppet; Frans Compernolle; Georges J. Hoornaert 📂 Article 📅 2000 🏛 Elsevier Science 🌐 French ⚖ 214 KB